title: Interval from Prostate Biopsy to Robot-Assisted Laparoscopic Radical Prostatectomy (RALP): Effects on Surgical Difficulties.
abstract: OBJECTIVE
  Traditionally, an interval of 4 to 6 weeks has been recommended after prostate biopsy before open radical prostatectomy. However, such an interval is not explicitly specified in robot-assisted laparoscopic radical prostatectomy (RALP). This study was designed to determine whether the interval from prostate biopsy to RALP affects surgical difficulties.
  
  
  METHODS
  Between January 2008 and May 2009, a total of 237 men underwent RALP in our institution. The interval from biopsy to RALP was categorized as follows: ≤ 2 weeks, >2 to ≤ 4 weeks, >4 to ≤ 6 weeks, >6 to ≤ 8 weeks, and >8 weeks. Multivariate analysis was used to identify whether the interval from prostate biopsy to RALP was an independent predictor of operative time, estimated blood loss (EBL), margin positivity, continence, and potency.
  
  
  RESULTS
  Among the 5 groups, there were no significant differences in age, body mass index (BMI), preoperative serum prostate-specific antigen (PSA), prostate volume, or preoperative International Index of Erectile Dysfunction-5 score (all p>0.05). In the multivariate analysis, operative time was significantly associated with prostate volume. EBL was associated with prostate volume and BMI. Margin positivity was associated with preoperative serum PSA, prostate volume, and biopsy Gleason score. Postoperative continence and potency were significantly associated with age. However, in univariate and multivariate analyses, the interval from biopsy to RALP was not significantly associated with operative time, EBL, margin positivity, postoperative continence, or potency (all p>0.05).
  
  
  CONCLUSIONS
  Our data suggest that the interval from prostate biopsy to RALP is not related to surgical difficulties.
authors.affiliation: Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
authors.forename: In Sung
authors.initials: IS
authors.lastname: Kim
authors.forename: Woong
authors.initials: W
authors.lastname: Na
authors.forename: Jung Su
authors.initials: JS
authors.lastname: Nam
authors.forename: Jong Jin
authors.initials: JJ
authors.lastname: Oh
authors.forename: Chang Wook
authors.initials: CW
authors.lastname: Jeong
authors.forename: Sung Kyu
authors.initials: SK
authors.lastname: Hong
authors.forename: Seok Soo
authors.initials: SS
authors.lastname: Byun
authors.forename: Sang Eun
authors.initials: SE
authors.lastname: Lee
references.citation: Urology. 2002 Nov;60(5):864-8
references.pmid: 12429317
references.citation: J Urol. 2008 Jan;179(1):136-40
references.pmid: 17997437
references.citation: Urology. 2005 Oct;66(4):808-13
references.pmid: 16230143
references.citation: Acta Radiol. 2001 Jan;42(1):70-3
references.pmid: 11167335
references.citation: BJU Int. 2005 Oct;96(6):773-6
references.pmid: 16153197
references.citation: Korean J Urol. 2010 Jan;51(1):30-3
references.pmid: 20414407
references.citation: J Urol. 2004 Nov;172(5 Pt 1):1835-9
references.pmid: 15540733
references.citation: BJU Int. 2009 Dec;104(11):1734-7
references.pmid: 19549123
references.citation: Urology. 2007 Jun;69(6):1128-33
references.pmid: 17572200
references.citation: BJU Int. 2006 Jan;97(1):48-50
references.pmid: 16336327
references.citation: BJU Int. 2003 Aug;92(3):205-10
references.pmid: 12887468
references.citation: Cancer Res Treat. 2009 Dec;41(4):205-10
references.pmid: 20057965